RoopaThukaramMD
Pediatrics • Tulsa, OKPediatric Critical Care Medicine
Pediatric Intensivist Associate professor of OU/OSU pediatric program
Dr. Thukaram is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6161 S Yale Ave
Tulsa, OK 74136Phone+1 918-502-6135
Education & Training
University of ColoradoFellowship, Pediatric Critical Care Medicine, 2006 - 2009
University of ToledoResidency, Pediatrics, 2003 - 2006
Mysore Medical CollegeClass of 1999
Certifications & Licensure
TX State Medical License 2019 - 2026
CO State Medical License 2007 - 2025
MA State Medical License 2024 - 2025
OK State Medical License 2009 - 2025
OH State Medical License 2003 - 2006- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Critical Care Medicine
Awards, Honors, & Recognition
- Family Centered Care Award Saint Francis Children's Hospital
Publications & Presentations
PubMed
- 1 citationsPosterior Reversible Encephalopathy Syndrome Complicating Ruptured Appendicitis and Abscess Drainage in a Previously Healthy Pediatric Patient.Taylor P. Saley, Alexander Barton, Shawn Berry Sood, Roopa Thukaram
Journal of Pediatric Intensive Care. 2019-06-01 - 3 citationsNeonatal Diabetes: Case Report of a 9-Week-Old Presenting Diabetic Ketoacidosis Due to an Activating ABCC8 Gene Mutation.Shawn Sood, Hannah Landreth, Jessee Bustinza, Laura J. Chalmers, Roopa Thukaram
Journal of Investigative Medicine High Impact Case Reports. 2017-03-24 - 54 citationsOsteopontin is an endogenous modulator of the constitutively activated phenotype of pulmonary adventitial fibroblasts in hypoxic pulmonary hypertension.Adil Anwar, Min Li, Maria G. Frid, Binod Kumar, Evgenia V. Gerasimovskaya
American Journal of Physiology. Lung Cellular and Molecular Physiology. 2012-07-01
Committees
- Medical Director, Pediatric code blue committee
- Physician leadership, Pediatric Sepsis Committee
- Medical Advisor, Safe Kids
Research History
- Sub investigatorA Multi-Center, Randomized, Open-Label, Parallel, Active-Comparator, Multiple Dose Trial to Determine the Efficacy, Safety, and Pharmacokinetics of Intravenous Ibuprofen in Pediatric Patients,2010 - 2013
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
